S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SCPH scPharmaceuticals Inc

2.8801

-0.2399 (-7.69%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more scPharmaceuticals Charts.

scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more scPharmaceuticals Charts.

scPharmaceuticals Inc News

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
Thursday 6 March 2025 (3 days ago) • GlobeNewswire Inc.

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 February 2025 (4 weeks ago) • Edgar (US Regulatory)

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 10 January 2025 (2 months ago) • Edgar (US Regulatory)

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
Friday 10 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday 13 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 28 August 2024 (6 months ago) • Edgar (US Regulatory)

More scPharmaceuticals Inc News Articles

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

Good Vibrations Shoes (PK)

Elite Pharmaceuticals (QB)

Lightwave Logic

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions